Financials

  • Market Capitalization 5.34 M
  • Employee 6
  • Founded 1994
  • CEO N/A
  • Website www.enveric.com
  • Headquarter Delaware, United States
  • FIGI BBG000BBQ281
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.09
Price to sales ratio
-2 840.35

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4902
MBRX
Moleculin Biotech, Inc. - Common Stock
0.97 USD-4.90%-54.46%-62.55%-69.21%5.18 M USD
4906
CURX
Curanex Pharmaceuticals Inc - Common Stock
0.20 USD+5.26%0.00%-31.03%-94.74%5.67 M USD
4912
NCNA
NuCana plc - American Depositary Shares
1.25 USD-0.79%-4.58%-18.30%-41.86%5.20 M USD
4913
GOVX
GeoVax Labs, Inc. - Common Stock
0.72 USD+2.86%-24.21%-42.40%-50.34%5.31 M USD

Frequently asked questions about Enveric Biosciences, Inc. - Common Stock

What is the Enveric Biosciences, Inc. - Common Stock stock price today?

The current price of Enveric Biosciences, Inc. - Common Stock (ENVB) is 1.45. Over the past 24 hours, the stock has changed by 0.00%. Follow the ENVB chart for real-time price dynamics.

What is the stock ticker of Enveric Biosciences, Inc. - Common Stock?

Enveric Biosciences, Inc. - Common Stock trades under the ticker ENVB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Enveric Biosciences, Inc. - Common Stock stock going up?

ENVB has changed by +14.17% over the last week, +5.07% over the last month, and -40.94% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?

Enveric Biosciences, Inc. - Common Stock currently has a market capitalization of 5.34 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Enveric Biosciences, Inc. - Common Stock earnings last quarter?

Last quarter, Enveric Biosciences, Inc. - Common Stock reported earnings of -1.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Enveric Biosciences, Inc. - Common Stock revenue for the last quarter?

Enveric Biosciences, Inc. - Common Stock reported quarterly revenue of -303. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Enveric Biosciences, Inc. - Common Stock net income for the last quarter?

Enveric Biosciences, Inc. - Common Stock reported net income of -1.63 M for the last quarter. The previous quarter showed -2.19 M, which means net income changed by +25.55%.

How many employees does Enveric Biosciences, Inc. - Common Stock have?

As of the latest available data, Enveric Biosciences, Inc. - Common Stock has 6 employees. Workforce size can provide additional context about the company's scale and operations.

What is Enveric Biosciences, Inc. - Common Stock EBITDA?

Enveric Biosciences, Inc. - Common Stock EBITDA is -2.85 M, and its EBITDA margin is 939.34 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Enveric Biosciences, Inc. - Common Stock stock?

You can buy Enveric Biosciences, Inc. - Common Stock (ENVB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Enveric Biosciences, Inc. - Common Stock stock?

Investing in Enveric Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENVB chart and related analysis on metatrader.com as part of your research.

News